INDIANAPOLIS, July 30 Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare brand, will issue its fiscal first quarter 2011 results on Monday, August 9, 2010. Arcadia will conduct a conference call and simultaneous internet webcast to review the financial results on Monday, August 9, 20
Rochester NY, www.shamrockstocks.com names Caleco Pharma Corp., Chembio Diagnostics, Inc., and Numobile, Inc. it's "Lucky Picks of the Day! To feature your publicly traded company in our alers email us at info@shamrockstocks.com. Also, you can receive up to the minute stock alerts via our Twitter page. www.twitter.com/shamrockstocks.
WHITEHOUSE STATION, N.J. Merck & Co., Inc. today announced financial results for the second quarter of 2010. Worldwide sales for the second quarter of 2010 were $11.3 billion. For the first six months of 2010, worldwide sales were $22.8 billion and net income was $1,051 million.
TRENTON, New Jersey After 20 months running drugmaker Sanofi-Aventis SA, Chris Viehbacher wants to end the roller coaster of revenue peaks and valleys as blockbuster drugs climb to billions in sales and suddenly plummet when generic competition hits.
July 30Almost anyone who has faced a test or a deadline probably wished there was a smart pill to pop. New research suggests that this may eventually be possible.
Dublin - Research and Markets has announced the addition of Frost & Sullivan's new report "Global Pharma-Biotech Alliance Analysis" to their offering. This Frost & Sullivan research service titled Global Pharma-Biotech Alliance Analysis provides a detailed analysis of the trends, opportunities, and unmet needs in the decision to enter emerging mark
Overview of Our Business. CVS Caremark Corporation is the largest pharmacy health care provider in the United States. We currently have three segments: Pharmacy Services, Retail Pharmacy and Corporate.
STOCK MARKETING INC PRESENTS : Viking Systems, Inc., Global Health Ventures, Inc., Applied Nanotech Holdings, Inc., Alternative Energy Partners Inc., Numobile, Inc., Chembio Diagnostics, Inc. www.StockMarketingInc.com. For More Information email us!!
www.HeroStocks.com. Giving Average Traders Super Powers One Alert At A Time! These stocks made it to our watch list... time to put them on yours! NPHC.OB / XCHO.OB / GNBT / VKNG.OB / ISCO. NPHC
Healthcare supplier Perrigo Company revealed on Monday the receipt of final approval from the US Food and Drug Administration to manufacture and market over-the-counter Cetirizine Cherry Syrup, 1mg/ml, for the treatment of indoor and outdoor allergy relief. The company plans to ship Cetirizine Cherry Syrup, 1mg/ml in the fiscal first quarter 2011.
ALLEGAN, Mich., July 26 Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter Cetirizine Cherry Syrup, 1mg/ml. The product will be marketed under store brand labels and is comparable to McNeil Consumer Healthcare's Zyrtec Children's Allergy Syrup,
